Manaus variant ‘may cause reinfection in up to 61% of people who have had Covid’

The Pfizer-BioNTech coronavirus vaccine is prepared for injection (Nick Potts/PA)
The Pfizer-BioNTech coronavirus vaccine is prepared for injection (Nick Potts/PA)